Sign in
TerminatedPhase 2

Sex Differences in Neurobehavioral Response to THC

Key facts

Who runs it
Medical University of South Carolina
Where
Charleston, United StatesSee the site
Trial code
Status
Terminated
Phase
Phase 2
People taking part
5 people enrolled
Started
27 Apr 2026
Ended
31 Aug 2026
Type of study
Interventional, 2 groups
Treatments tested
  • Dronabinol
  • Placebo
Record updated
6 October 2026
Why it stopped
Funding status change.

Who can take part

Age
21 years to 45 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Age 21-45
  • DSM-5 criteria for CUD
  • Cannabis use ≥4 days/week
  • THC-positive urine
  • BMI 18-30
  • Regular menstrual cycle (females)
  • Willingness to use non-hormonal birth control (females)

Who cannot take part

  • Recent drug use other than cannabis
  • Current psychotropic medication
  • Lifetime psychotic or bipolar disorder
  • Current psychiatric disorder (except mild alcohol, nicotine, or caffeine use disorder)
  • Treatment-seeking for SUD
  • Pregnancy/nursing
  • MRI contraindications

Where in United States

  • Medical University of South CarolinaCharleston, United States

About the trial

What the trial wants to find out

This study investigates sex differences in reward processing following acute THC administration in adults with cannabis use disorder (CUD). Using multimodal neuroimaging (MRS and fMRI), the study will assess glutamate levels in the nucleus accumbens and striatal BOLD response to monetary reward anticipation. Participants will complete two counterbalanced dosing sessions (oral THC 40 mg vs. placebo).

The 2 groups in the trial

  • MalesOther group

    Treatment: Dronabinol and Placebo

  • FemalesOther group

    Treatment: Dronabinol and Placebo

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Sex Differences in Neurobehavioral Response to Acute THC in Adults With Cannabis Use Disorder
Record updated
6 October 2026